Argitalpenak (52) MARIA ANTONIA NOGUERA ROMERO argitalpenak

2024

  1. Adenosine A2B receptor agonist improves epidermal barrier integrity in a murine model of epidermal hyperplasia

    Biomedicine and Pharmacotherapy, Vol. 173

2021

  1. Annexin A2-Mediated Plasminogen Activation in Endothelial Cells Contributes to the Proangiogenic Effect of Adenosine A2A Receptors

    Frontiers in Pharmacology, Vol. 12

  2. Elaboración de documentos multimedia sobre noticias farmacológicas como recurso docente

    Universidad, innovación e investigación ante el horizonte 2030 (Egregius)

  3. Elaboración de documentos multimedia sobre noticias farmacológicas como recurso docente

    Docencia, ciencia y humanidades: hacia una enseñanza integral en la universidad del siglo XXI (Dykinson), pp. 1354-1369

  4. NT3/TrkC Pathway Modulates the Expression of UCP-1 and Adipocyte Size in Human and Rodent Adipose Tissue

    Frontiers in Endocrinology, Vol. 12

2017

  1. Activation of α1A-adrenoceptors desensitizes the rat aorta response to phenylephrine through a neuronal NOS pathway, a mechanism lost with ageing

    British Journal of Pharmacology, Vol. 174, Núm. 13, pp. 2015-2030

2015

  1. β2-and β1-adrenoceptor expression exhibits a common regulatory pattern with GRK2 and GRK5 in human and animal models of cardiovascular diseases

    Journal of Cardiovascular Pharmacology, Vol. 66, Núm. 5, pp. 478-486

2014

  1. Action of an extract from the seeds of Fraxinus excelsior L. on metabolic disorders in hypertensive and obese animal models

    Food and Function, Vol. 5, Núm. 4, pp. 786-796

  2. Changes in adrenoceptors and G-protein-coupled receptor kinase 2 in L-NAME-induced hypertension compared to spontaneous hypertension in rats

    Journal of Vascular Research, Vol. 51, Núm. 3, pp. 209-220

2013

  1. Differences in the Signaling Pathways of α1A- and α1B-Adrenoceptors Are Related to Different Endosomal Targeting

    PLoS ONE, Vol. 8, Núm. 5

  2. Different β-adrenoceptor subtypes coupling to cAMP or NO/cGMP pathways: Implications in the relaxant response of rat conductance and resistance vessels

    British Journal of Pharmacology, Vol. 169, Núm. 2, pp. 413-425

  3. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1833, Núm. 10, pp. 2322-2333

  4. α1D-Adrenoceptors are responsible for the high sensitivity and the slow time-course of noradrenaline-mediated contraction in conductance arteries

    Pharmacology Research and Perspectives, Vol. 1, Núm. 1

2010

  1. Farmacinema: recurso docente en el aprendizaje de Farmacología y Farmacia Clínica

    Ars pharmaceutica, Vol. 51, Núm. 1, pp. 169-176

2008

  1. Anisakis simplex s.l.: Larvicidal activity of various monoterpenic derivatives of natural origin against L3 larvae in vitro and in vivo

    Experimental Parasitology, Vol. 120, Núm. 4, pp. 295-299

2005

  1. 8-NH2-boldine, an antagonist of α1A and α1B adrenoceptors without affinity for the α1D subtype: Structural requirements for aporphines at α1- adrenoceptor subtypes

    Planta Medica, Vol. 71, Núm. 10, pp. 897-903

  2. Acute and chronic captopril, but not prazosin or nifedipine, normalize alterations in adrenergic intracellular Ca2+ handling observed in the mesenteric arterial tree of spontaneously hypertensive rats

    Journal of Pharmacology and Experimental Therapeutics, Vol. 313, Núm. 1, pp. 359-367

2004

  1. Vascular activity of (-)-anonaine, (-)-roemerine and (-)-pukateine, three natural 6a(R)-1,2-methylenedioxyaporphines with different affinities for α1-adrenoceptor subtypes

    Planta Medica, Vol. 70, Núm. 7, pp. 603-609

2003

  1. Cytosolic Ca2+ and phosphoinositide hydrolysis linked to constitutively active α1D-adrenoceptors in vascular smooth muscle

    Journal of Pharmacology and Experimental Therapeutics, Vol. 305, Núm. 3, pp. 1006-1014

  2. Functional characterization of α1-adrenoceptor subtypes in vascular tissues using different experimental approaches: A comparative study

    British Journal of Pharmacology, Vol. 138, Núm. 2, pp. 359-368